Wegovy vs Saxenda: Which is Better for Weight Loss?

By Craig Sorkin, DNP, APN
Medically reviewed checkmarkMedically reviewed
July 14, 2022

Wegovy and Saxenda are two medications in the class of drugs called glucagon-like peptide-1s receptor agonists (GLP-1s). 

Also known as incretin mimetics, GLP-1s are medications that have been proven effective in the treatment of type 2 diabetes and weight loss. Examples of other GLP-1 medications include dulaglutide (Trulicity) and semaglutide (Ozempic).

Both Wegovy and Saxenda have been shown to be effective in support of weight loss when combined with behavioral modifications including diet and exercise. 

In this article, I’ll go over what Wegovy and Saxenda are, why they’re effective, and their dosages. I’ll also cover potential side effects and cost. 

What Is Wegovy?

Wegovy is a GLP-1 medication that delivers an active compound called semaglutide. Semaglutide was originally approved as a diabetes medication in 2017, sold under the brand name Ozempic. 

Though both Wegovy and Ozempic contain the same active compound, Wegovy contains a much higher dose of semaglutide. It received FDA approval as a weight loss medication in 2021, the first new weight loss medication to gain approval in several years.

Manage weight loss online

See if you’re a good fit for K Health’s online medical weight loss program.

Start now

What is Saxenda?

Saxenda is a GLP-1 medication that delivers an active compound called liraglutide.

Liraglutide was originally approved by the FDA as an adjunct therapy to diet and exercise for management of type 2 diabetes in 2010, sold under the brand name Victoza. 

But following clinical trial results, liraglutide sold under the name Saxenda gained approval in 2017 as a weight loss medication for people with a BMI of 30 or higher or people with a BMI of 27 and higher who also have a metabolic health condition. 

Importantly, Saxenda is not used to treat type 2 diabetes.

Wegovy vs. Saxenda

Wegovy and Saxenda are both FDA approved GLP-1 medications that have been shown to be effective at supporting weight loss in certain individuals when combined with other lifestyle modifications, chiefly diet and exercise. 

Though they’re both GLP-1s, they contain different active compounds: Wegovy delivers the active compound while Saxenda contains the active compound liraglutide. 

Both medications are also manufactured by the same Danish pharmaceutical company, Novo Nordisk.

Though the medications contain different active compounds, they work similarly to promote metabolic health and support weight loss. 

The majority of research investigating how GLP-1s work to support weight loss focus on liraglutide. 

Research suggests that these GLP-1 medications help to improve insulin production in the pancreas, slow down the rate of stomach emptying, and stabilize glucose and insulin levels after eating. 

These results suggest that GLP-1s ultimately help to lower insulin levels, reduce appetite, and decrease muscle insulin sensitivity—all of which helps to support weight loss.

Effectiveness

Both medications have been shown to be safe and effective treatments in support of weight loss. 

In fact, the class of GLP-1 medications has been researched for over 16 years and has repeatedly shown promising results in the reduction of body weight in obese patients with and without diabetes.

Wegovy

Results of a double-blind trial of almost 2,000 adults with a BMI of 30 or higher found that 50% of participants were able to lose at least 15% of their initial body weight when taking semaglutide alongside behavioral modifications.

Additional research suggests that Wegovy not only showed effectiveness in improving in diabetes and body weight but may also help to lower the rate of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke in patients with type 2 diabetes at high risk of cardiovascular disease. 

Some research, including the results of SUSTAIN (semaglutide unabated sustainability in treatment of type 2 diabetes) and STEP (semaglutide treatment effect in people with obesity) suggest that semaglutide (the active compound in Wegovy) may be more effective in support of weight loss than liraglutide (the active compound in Saxenda). 

But, as with any research, it’s important to remember that what works best for you may not be the same medication that works best for the majority of people under similar circumstances.

Saxenda

Results of five randomized, placebo-controlled trials found that, in addition to recommended diet and physical activity, Saxenda consistently resulted in helping patients to lose at least 5-10% of their body weight when compared with placebo. 

Research also suggests that Saxenda may offer long-term cardiovascular benefits, too, including improved glycemic control.

It’s important to keep in mind that neither of these medications offer a “quick-fix” for weight loss. 

To effectively and safely reap the benefits of either medication, you should work closely with your medical provider to ensure that you’re consistently incorporating lifestyle modifications while on one of these medications. 

Following your provider’s diet and exercise recommendations is key to ensuring long-term and sustainable weight loss success with these medications.

Dosage

Importantly, both Wegovy and Saxenda are generally delivered via injection. However, Wegovy is administered once weekly while Saxenda is administered once daily.

Wegovy

If you’re prescribed Wegovy, your provider will start you on a low dose and gradually increase the dose over 16-20 weeks until you reach a dosage of 2.4 mg delivered once weekly. 

Gradually increasing the dose of the medication may help to reduce the risk of gastrointestinal side effects. 

Saxenda

Similarly to Wegovy, if you’re prescribed Saxenda, your provider will start you on a low dose of 0.6 mg per day and gradually increase the dose weekly by 0.6mg for four weeks until you reach a dosage of 3.0 mg. 

Side Effects

Both Wegovy and Saxenda can cause side effects. The most common side effects are gastrointestinal. 

Wegovy

74% of those on Wegovy (semaglutide) reported at least one gastrointestinal side effect. The most common side effects of Wegovy include:

Serious side effects are less common, but possible. If you experience any of the following, seek emergency treatment:

  • Ongoing pain that begins in the upper left or middle of the stomach but may spread to the back, with or without vomiting
  • Rash; itching
  • Swelling of the eyes, face, mouth, tongue, or throat
  • Difficulty breathing or swallowing
  • Decreased urination
  • Swelling of legs, ankles, or feet
  • Vision changes
  • Fainting or dizziness
  • Pain in upper stomach
  • Yellowing of skin or eyes
  • Fever
  • Clay-colored stools 
  • Rapid heartbeat

Saxenda

The most common side effects of Saxenda include:

Unfortunately, serious side effects are also possible with Saxenda. If you experience any of the following, seek emergency treatment:

  • Ongoing pain that begins in the upper left or middle of the stomach but can spread to the back
  • New or worsening depression
  • Suicidal ideation (thinking about harming or killing yourself)
  • Unusual changes in mood or behavior
  • Vomiting
  • Nausea
  • Diarrhea
  • Clay-colored stools
  • Yellow eyes or skin
  • Heart pounding
  • Fainting or feeling dizzy
  • Swelling of the eyes, face, mouth, tongue, or throat
  • Rash
  • Itching
  • Difficulty breathing or swallowing

Manage weight loss online

See if you’re a good fit for K Health’s online medical weight loss program.

Start now

Cost

Wegovy

The cost of Wegovy can vary depending on several factors, including your insurance coverage and the rates at your local pharmacy.

Without insurance, Wegovy can cost over $1,500 per month. With coverage, you may pay as little as $25 per month. 

Saxenda

The cost of Saxenda is similar to the cost of Wegovy.

Without insurance, monthly rates can be $1,300 or more. But with insurance, the monthly cost of Saxenda can be as little as $25 per month. 

Which is Better?

Results of the Step 8 Randomized Clinical Trial found that semaglutide resulted in significantly greater weight loss at 68 weeks in obese and overweight adults with or without diabetes (importantly, the two medications were not compared in phase III trials). 

However, what works best for you will depend on several factors, including your medical history and current health.

If you’re interested in weight loss medication as an adjunct therapy for behavioral modifications, reach out to your medical provider to discuss which options may be best for you.

Manage Weight Loss with K Health

Get Saxenda or Ozempic online using K Health for just $29 per month.

It’s just three easy steps:

  1. Answer a few simple questions.
  2. Meet your primary care provider.
  3. Get the care you need.

Start now.

Frequently Asked Questions

Is Wegovy better than Saxenda for weight loss?
Results of the Step 8 Randomized Clinical Trial found that semaglutide resulted in significantly greater weight loss at 68 weeks in obese and overweight adults with or without diabetes. Results of other trials, including the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) and PIONEER (Peptide Innovation for Early Diabetes) clinical trial programs also found Wegovy to result in greater weight loss. However, what works best for you may be different than the results of these trials.
Are Wegovy and Saxenda the same?
Wegovy and Saxenda are both antidiabetic medications that have been approved by the FDA for clinical weight management. They are both glucagon-like peptide-1s receptor agonists (GLP-1s), but they contain different active compounds. Wegovy contains semaglutide while Saxenda contains liraglutide.
Can I switch from Saxenda to Wegovy?
If your provider deems a switch in medication safe, you can switch from Saxenda to Wegovy while under their supervision.
What medication is similar to Wegovy?
Wegovy is a glucagon-like peptide-1s receptor agonists (GLP-1s) that contains the active compound semaglutide. Examples of other GLP-1s include liraglutide (Saxenda), dulaglutide (Trulicity), and semaglutide (Ozempic).
K Health articles are all written and reviewed by MDs, PhDs, NPs, or PharmDs and are for informational purposes only. This information does not constitute and should not be relied on for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment.

Craig Sorkin, DNP, APN

Craig Sorkin, DNP, APN is a board certified Family Nurse Practitioner with over 15 years experience. He received his Undergraduate and Graduate degrees from William Paterson University and his doctoral degree from Drexel University. He has spent his career working in the Emergency Room and Primary Care. The last 6 years of his career have been dedicated to the field of digital medicine. He has created departments geared towards this specialized practice as well as written blogs and a book about the topic.

Close button

See if you qualify for online prescription weight loss medication.

Start now
Chesney Fowler